Retrospective evaluation of the effect of high flow oxygen therapy delivered by nasal cannula on PaO2 in dogs with moderate‐to‐severe hypoxemia
Journal of Veterinary Emergency and Critical Care2016Vol. 26(4), pp. 598–602
Citations Over TimeTop 10% of 2016 papers
Abstract
These data suggest HFOT is a viable clinical intervention for dogs with moderate-to-severe hypoxemia assessed to be failing TOT. Further studies are needed to determine if HFOT can be used as an alternative to mechanical ventilation in resource limited settings and to characterize the complications associated with this therapy.
Related Papers
- → Domiciliary High-Flow Nasal Cannula Oxygen Therapy for Patients with Stable Hypercapnic Chronic Obstructive Pulmonary Disease. A Multicenter Randomized Crossover Trial(2017)108 cited
- → Novel Nasal High Flow Cannula Usability Performance Characteristics(2016)
- → Progress of high-flow nasal cannula oxygen therapy in respiratory diseases(2019)
- → Evaluation of Clinical and Epidemiological Features of Patients Receiving High-Flow Nasal Cannula Oxygen Therapy in Pediatric Intensive Care Unit(2021)
- → Can High-Flow Nasal Cannula Oxygen Therapy Improve Respiratory Status in Hospitalized Patients With COVID-19?(2022)